Technical Analysis for WVE - WAVE Life Sciences Ltd.

Grade Last Price % Change Price Change
grade F 25.41 5.04% 1.22
WVE closed up 5.04 percent on Friday, May 24, 2019, on 64 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical WVE trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 5.04%
Lower Bollinger Band Walk Weakness 5.04%
BB Squeeze Ended Range Expansion 5.04%
Below Lower BB Weakness 5.04%
Lower Bollinger Band Touch Weakness 5.04%
Oversold Stochastic Weakness 5.04%

Older signals for WVE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company was founded in 2012 and is based in Singapore.
Rare Diseases Medical Genetics Inflammatory Bowel Disease Muscular Dystrophy Huntington's Disease Duchenne Muscular Dystrophy Genetic Genealogy Genodermatoses Cytoskeleton Dystrophin Ibd SNP
Is WVE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 56.0
52 Week Low 22.9
Average Volume 503,172
200-Day Moving Average 41.3984
50-Day Moving Average 32.5622
20-Day Moving Average 26.6365
10-Day Moving Average 25.868
Average True Range 1.5683
ADX 35.77
+DI 12.0979
-DI 27.2232
Chandelier Exit (Long, 3 ATRs ) 23.9051
Chandelier Exit (Short, 3 ATRs ) 28.7949
Upper Bollinger Band 28.9796
Lower Bollinger Band 24.2934
Percent B (%b) 0.24
BandWidth 17.593152
MACD Line -1.8789
MACD Signal Line -2.0575
MACD Histogram 0.1786
Fundamentals Value
Market Cap 705.38 Million
Num Shares 27.8 Million
EPS -3.35
Price-to-Earnings (P/E) Ratio -7.59
Price-to-Sales 250.07
Price-to-Book 3.20
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.11
Resistance 3 (R3) 27.97 26.93 27.66
Resistance 2 (R2) 26.93 26.24 27.00 27.51
Resistance 1 (R1) 26.17 25.82 26.55 26.31 27.36
Pivot Point 25.13 25.13 25.32 25.20 25.13
Support 1 (S1) 24.37 24.44 24.75 24.51 23.46
Support 2 (S2) 23.33 24.02 23.40 23.31
Support 3 (S3) 22.57 23.33 23.16
Support 4 (S4) 22.71